Meropenem + moxifloxacin: no improvement over meropenem alone in severe sepsis (RCT)
www.pulmccm.org
In the first randomized trial of its kind, patients with severe sepsis or septic shock who were given meropenem alone had equivalent clinical outcomes to patients who were given combination therapy including meropenem and moxifloxacin.
Meropenem + moxifloxacin: no improvement over meropenem alone in severe sepsis (RCT)
Meropenem + moxifloxacin: no improvement over…
Meropenem + moxifloxacin: no improvement over meropenem alone in severe sepsis (RCT)
In the first randomized trial of its kind, patients with severe sepsis or septic shock who were given meropenem alone had equivalent clinical outcomes to patients who were given combination therapy including meropenem and moxifloxacin.